Clinicopathologic characteristics of nodal follicular lymphomas lacking IgH/BCL2 translocations

被引：0
|
作者：
Keller, C. [1 ]
Subramaniyam, S. [1 ]
Murty, V. [1 ]
Alobeid, B. [1 ]
Bhagat, G. [1 ]
机构：
[1] Columbia Univ, New York, NY USA
来源：
MODERN PATHOLOGY | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1133
引用
收藏
页码：247A / 248A
页数：2
相关论文
共 50 条
  • [31] B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas
    Li, Shaoying
    Seegmiller, Adam C.
    Lin, Pei
    Wang, Xuan J.
    Miranda, Roberto N.
    Bhagavathi, Sharathkumar
    Medeiros, L. Jeffrey
    MODERN PATHOLOGY, 2015, 28 (02) : 208 - 217
  • [32] Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus
    Leich, E.
    Hoster, E.
    Wartenberg, M.
    Unterhalt, M.
    Siebert, R.
    Koch, K.
    Klapper, W.
    Engelhard, M.
    Puppe, B.
    Horn, H.
    Staiger, A. M.
    Stuhlmann-Laeisz, C.
    Bernd, H. W.
    Feller, A. C.
    Hummel, M.
    Lenze, D.
    Stein, H.
    Hartmann, S.
    Hansmann, M. L.
    Moeller, P.
    Hiddemann, W.
    Dreyling, M.
    Ott, G.
    Rosenwald, A.
    LEUKEMIA, 2016, 30 (04) : 854 - 860
  • [33] Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular Lymphoma
    Fernandez-Pol, Sebastian
    Bangs, Charles D.
    Cherry, Athena
    Arber, Daniel A.
    Gratzinger, Dita
    HUMAN PATHOLOGY, 2016, 55 : 39 - 43
  • [34] Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus
    E Leich
    E Hoster
    M Wartenberg
    M Unterhalt
    R Siebert
    K Koch
    W Klapper
    M Engelhard
    B Puppe
    H Horn
    A M Staiger
    C Stuhlmann-Laeisz
    H W Bernd
    A C Feller
    M Hummel
    D Lenze
    H Stein
    S Hartmann
    M L Hansmann
    P Möller
    W Hiddemann
    M Dreyling
    G Ott
    A Rosenwald
    Leukemia, 2016, 30 : 854 - 860
  • [35] Serum BCL2/IGH DNA in follicular lymphoma patients:: A minimal residual disease marker
    Gocke, CD
    Kopreski, MS
    Benko, FA
    Sternas, L
    Kwak, LW
    LEUKEMIA & LYMPHOMA, 2000, 39 (1-2) : 165 - 172
  • [36] Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma
    A Barreca
    C Martinengo
    L Annaratone
    L Righi
    A Chiappella
    M Ladetto
    A Demurtas
    L Chiusa
    A Stacchini
    N Crosetto
    A van Oudenaarden
    R Chiarle
    Blood Cancer Journal, 2014, 4 : e249 - e249
  • [37] Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma
    Barreca, A.
    Martinengo, C.
    Annaratone, L.
    Righi, L.
    Chiappella, A.
    Ladetto, M.
    Demurtas, A.
    Chiusa, L.
    Stacchini, A.
    Crosetto, N.
    van Oudenaarden, A.
    Chiarle, R.
    BLOOD CANCER JOURNAL, 2014, 4 : e249 - e249
  • [38] The Pattern of BCL6 Intron 1 Mutations in Healthy Individuals with BCL2;IgH Is Similar to That Seen in Lymphomas
    Worrillow, Lisa J.
    Newton, Rob
    Jack, Andrew S.
    BLOOD, 2008, 112 (11) : 1300 - 1300
  • [39] Correlation between histological subtype and type of bcl-2/IgH rearrangement in follicular lymphomas
    Colleoni, GWB
    Duarte, LCC
    Kerbauy, BR
    Noguti, MAE
    De Silva, IDCG
    Otsuka, AY
    Alves, AC
    Silva, MRR
    LEUKEMIA & LYMPHOMA, 2004, 45 (02) : 331 - 338
  • [40] High-Grade B-Cell Lymphomas with Concurrent MYC and BCL2 Abnormalities Other Than Translocations Behave Similarly to MYC/BCL2 Double Hit Lymphomas
    Li, S.
    Seegmiller, A.
    Lin, P.
    Medeiros, L. J.
    MODERN PATHOLOGY, 2013, 26 : 341A - 341A
12345